Biomarkers for evaluating early colorectal cancer
A biomarker, colorectal cancer technology, applied in biochemical equipment and methods, microbial determination/examination, instruments, etc., can solve problems affecting the treatment and prognosis of colorectal cancer patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0116] Example 1 Screening of differentially expressed genes associated with colorectal cancer
[0117] 1. Sample source
[0118] Download the sequencing data of the PRJEB27536 data set from SRA and the colorectal cancer gene expression data from TCGA. The sample size is normal tissue: polyp tissue: colorectal cancer TNM1: TNM2: TNM3: TNM4 = 50:21:52:123:89: 44.
[0119] 2. Data processing
[0120] The raw data from the SRA database was processed and quality-controlled using fastq software, and the obtained cleandata was compared to the human reference genome using ICGC software (GRCh38.d1.vd1), and the bam file was quantified using htseq software.
[0121] quantitative mode: intersection-nonempty;
[0122] Quantitative standard type: gene_id;
[0123] Chain specificity: non-specific.
[0124] The expression level files are merged according to the gene ID to construct an M*N gene expression level matrix. The value in the i-th row and j-column in the gene expression level ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com